» Articles » PMID: 32367055

The Continued Threat of Emerging Flaviviruses

Overview
Journal Nat Microbiol
Date 2020 May 6
PMID 32367055
Citations 421
Authors
Affiliations
Soon will be listed here.
Abstract

Flaviviruses are vector-borne RNA viruses that can emerge unexpectedly in human populations and cause a spectrum of potentially severe diseases including hepatitis, vascular shock syndrome, encephalitis, acute flaccid paralysis, congenital abnormalities and fetal death. This epidemiological pattern has occurred numerous times during the last 70 years, including epidemics of dengue virus and West Nile virus, and the most recent explosive epidemic of Zika virus in the Americas. Flaviviruses are now globally distributed and infect up to 400 million people annually. Of significant concern, outbreaks of other less well-characterized flaviviruses have been reported in humans and animals in different regions of the world. The potential for these viruses to sustain epidemic transmission among humans is poorly understood. In this Review, we discuss the basic biology of flaviviruses, their infectious cycles, the diseases they cause and underlying host immune responses to infection. We describe flaviviruses that represent an established ongoing threat to global health and those that have recently emerged in new populations to cause significant disease. We also provide examples of lesser-known flaviviruses that circulate in restricted areas of the world but have the potential to emerge more broadly in human populations. Finally, we discuss how an understanding of the epidemiology, biology, structure and immunity of flaviviruses can inform the rapid development of countermeasures to treat or prevent human infections as they emerge.

Citing Articles

Decoding dengue's neurological assault: insights from single-cell CNS analysis in an immunocompromised mouse model.

Qiu M, Zhao L, Li X, Fan Y, Liu M, Hua D J Neuroinflammation. 2025; 22(1):62.

PMID: 40038739 PMC: 11877810. DOI: 10.1186/s12974-025-03383-w.


Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort.

Wullimann D, Sandberg J, Akber M, Lofling M, Gredmark-Russ S, Michaelsson J PLoS Negl Trop Dis. 2025; 19(2):e0012693.

PMID: 40019865 PMC: 11893121. DOI: 10.1371/journal.pntd.0012693.


Towards a Universal Translator: Decoding the PTMs That Regulate Orthoflavivirus Infection.

Schmidt H, Horner S Viruses. 2025; 17(2).

PMID: 40007042 PMC: 11861903. DOI: 10.3390/v17020287.


Viruses and the Brain-A Relationship Prone to Trouble.

Mielcarska M, Rouse B Viruses. 2025; 17(2).

PMID: 40006958 PMC: 11860391. DOI: 10.3390/v17020203.


Bussuquara Virus: A Neglected Orthoflavivirus with Broad Distribution Across Central and South America and the Caribbean.

Steck M, Buenemann M, Vasilakis N Viruses. 2025; 17(2).

PMID: 40006938 PMC: 11861595. DOI: 10.3390/v17020183.


References
1.
Bhatt S, Gething P, Brady O, Messina J, Farlow A, Moyes C . The global distribution and burden of dengue. Nature. 2013; 496(7446):504-7. PMC: 3651993. DOI: 10.1038/nature12060. View

2.
Gubler D . Dengue/dengue haemorrhagic fever: history and current status. Novartis Found Symp. 2007; 277:3-16. DOI: 10.1002/0470058005.ch2. View

3.
Pierson T, Diamond M . The emergence of Zika virus and its new clinical syndromes. Nature. 2018; 560(7720):573-581. DOI: 10.1038/s41586-018-0446-y. View

4.
Roehrig J . West nile virus in the United States - a historical perspective. Viruses. 2013; 5(12):3088-108. PMC: 3967162. DOI: 10.3390/v5123088. View

5.
Faria N, Kraemer M, Hill S, Goes de Jesus J, Aguiar R, Iani F . Genomic and epidemiological monitoring of yellow fever virus transmission potential. Science. 2018; 361(6405):894-899. PMC: 6874500. DOI: 10.1126/science.aat7115. View